中泛控股(00715.HK)接獲法定要求償債書 索償2284.83萬美元
格隆匯8月3日丨中泛控股(00715.HK)宣佈,2023年8月3日,公司接獲總承包商律師代表根據1981年公司法第162條所發出日期為2023年8月1日的法定要求償債書("法定要求償債書"),當中要求公司於法定要求償債書送達之日起計21天內支付金額22,848,286.25美元(為結欠總承包商的款項總額連同截至2023年7月18日的累計利息),否則總承包商可向百慕達最高法院提出呈請,要求百慕達最高法院頒令將公司清盤。
公司正就此尋求法律意見,並與總承包商進行商討,以達成友好解決方案。公司將適時或根據上市規則的規定就法定要求償債書再作公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.